Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples

Meir Medical Center30 enrolled

Overview

The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients in relation to the clinical manifestations of the disease.

Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target of variation of the blood level vitamin D antibody between this groups

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Scleroderma

Interventions

Blood sampleOTHER

blood sample, venous blood, about 10 ml will be drawn from participants

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: study group 1. patients with SSc 2. age - 18 years old and older 3. sign ICF control group - healthy people

Outcomes

Primary Outcomes

Presence of anti vitamin D antibodies in scleroderma patients compared with control

Time frame: March 2013 (up to one year)

Secondary Outcomes

Anti vitamin D presence and levels in serum in relation to the clinical manifestations of scleroderma

Time frame: March 2013 (up to one year)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.